Chemoinformaics analysis of Isoquinolines (Benzophenanthridine
Molecular Weight | 229.282 | nRot | 0 |
Heavy Atom Molecular Weight | 218.194 | nRig | 21 |
Exact Molecular Weight | 229.089 | nRing | 4 |
Solubility: LogS | -6.58 | nHRing | 1 |
Solubility: LogP | 4.664 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 3 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 18 |
No. of Oxygen atom | 0 | No. of Arom Bond | 21 |
nHA | 1 | APOL | 36.8247 |
nHD | 0 | BPOL | 12.1753 |
QED | 0.403 |
Synth | 1.745 |
Natural Product Likeliness | -0.32 |
NR-PPAR-gamma | 0.952 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.024 |
Pgp-sub | 0.606 |
HIA | 0.018 |
CACO-2 | -4.737 |
MDCK | 0.0000176 |
BBB | 0.826 |
PPB | 0.973393 |
VDSS | 2.054 |
FU | 0.00834758 |
CYP1A2-inh | 0.992 |
CYP1A2-sub | 0.218 |
CYP2c19-inh | 0.643 |
CYP2c19-sub | 0.087 |
CYP2c9-inh | 0.457 |
CYP2c9-sub | 0.883 |
CYP2d6-inh | 0.562 |
CYP2d6-sub | 0.912 |
CYP3a4-inh | 0.407 |
CYP3a4-sub | 0.164 |
CL | 5.06 |
T12 | 0.164 |
hERG | 0.356 |
Ames | 0.878 |
ROA | 0.151 |
SkinSen | 0.947 |
Carcinogencity | 0.814 |
EI | 0.988 |
Respiratory | 0.953 |
NR-Aromatase | 0.377 |
Antiviral | No |
Prediction | 0.59545 |